Molecular mechanisms of development of gastric carcinoma by Epstein-Barr virus
Molecular mechanisms of development of gastric carcinoma by Epstein-Barr virus
批准号:
12213001
负责人:
TAKADA Kenzo
金额:
$29.57万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research on Priority Areas
财政年份:
2000
资助国家:
日本
项目状态:
已结题
起止时间:
2000 至 2004
中文摘要
点击翻译按钮获取中文摘要
英文摘要
This project aimed at clarifying molecular mechanisms of gastric carcinoma induction by EBV, and obtained the following findings.1. There are two distinct pathways in EBV infection of epithelial cells, a gp350-dependent pathway and a gp350-independent pathway, and gp25 can play a role in the infection of some epithelial cells.2. EBV-encoded small RNA (EBER) binds interferon-inducible protein kinase, PKR, inhibits its phosphorylaltion, and confers resistance to FAS-mediated apoptosis in epithelial cells.3. EBER induces insulin-like growth factor 1 (IGF-1) and promotes autocrine growth of EBV-positive gastric carcinoma.4. EBV BARF1 gene is known to be a lytic gene and to induce malignant transformation of rodent fibroblasts. We demonstrated that BARF1 is expressed in most EBV-positive gastric carcinoma tissues as a latent gene.5. It is known that EBV latent membrane protein 2A (LMP2A) gene is expressed in the majority of EBV-positive gastric carcinoma tissues. We demonstrated that LMP2A confers resistance to anoikis in epithelial cells via activation of ERK.
期刊论文(70)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Epstein-Barr virus (EBV)-encoded BARF1 gene is expressed in nasopharyngeal carcinoma and EBV-associated gastric carcinoma tissues in the absence of lytic gene expression: implication of a new EBV latency type.
EB 病毒 (EBV) 编码的 BARF1 基因在鼻咽癌和 EBV 相关胃癌组织中表达,但没有裂解基因表达:新的 EBV 潜伏类型的暗示。
DOI:
--
发表时间:
2005
期刊:
J. Med. Virol. 76
影响因子:
--
作者:
[Seto, E., Yang, L., Middeldorp, J., Sheen, J.S., Chen, J.Y., Eizuru, Y., Takada, K.]
通讯作者:
K.
Yang, L.: "Epstein-Barr virus infection of rat lymphocytes expressing human CD21 results in restricted latent viral gene expression but not in immunoblastic transformation"J. Med. Virol.. 70. 126-130 (2003)
Yang, L.:“表达人 CD21 的大鼠淋巴细胞感染 Epstein-Barr 病毒会导致潜在病毒基因表达受限,但不会导致免疫母细胞转化”J.
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Trivedi, P.: "Infection of HHV-8 positive primary effusion lymphoma cells with a recombinant Epstein-Barr virus leads to restricted EBV latency, altered phenotype and increased tumorigenicity without affecting TCL1 expression"Blood. 103. 313-316 (2004)
Trivedi, P.:“用重组 Epstein-Barr 病毒感染 HHV-8 阳性原发性渗出性淋巴瘤细胞会导致 EBV 潜伏期受限、表型改变和致瘤性增加,而不影响 TCL1 表达”Blood。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Konishi, K.: "Role of Epstein-Barr virus-encoded latent membrane protein 2A on virus-induced transformation and virus activation"J. Gen. Virol.. 82. 1457-1463 (2001)
Konishi, K.:“Epstein-Barr 病毒编码的潜伏膜蛋白 2A 对病毒诱导的转化和病毒激活的作用”J。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Nanbo, A.: "The role of Epstein-Barr virus-encoded small RNAs (EBERs) in oncogenesis"Rev. Med. Virol.. 12・5. 321-326 (2002)
Nanbo,A.:“Epstein-Barr 病毒编码的小 RNA (EBER) 在肿瘤发生中的作用”Rev. Virol. 12・5 (2002)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 32 条
Molecular mechanisms of development of stomach cancer by Epstein-Barr virus
-
批准号:17013002
-
项目类别:Grant-in-Aid for Scientific Research on Priority Areas
-
资助金额:$34.24万
-
财政年份:2005
-
负责人:TAKADA Kenzo
-
依托单位:
The Role of Epstein-Barr virus encoded small RNAs (EBERs)
-
批准号:15390147
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$9.86万
-
财政年份:2003
-
负责人:TAKADA Kenzo
-
依托单位:
Analysis of functions of Epstein-Barr virus-encoded small RNA EBER
-
批准号:13470062
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$8.0万
-
财政年份:2001
-
负责人:TAKADA Kenzo
-
依托单位:
Development of a model animal for Epstein-Barr virus infection
-
批准号:12557028
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$8.45万
-
财政年份:2000
-
负责人:TAKADA Kenzo
-
依托单位:
Role of Epstein-Barr virus-encoded latent membrane protein 2A on maintenance of latent infection
-
批准号:11470073
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$10.11万
-
财政年份:1999
-
负责人:TAKADA Kenzo
-
依托单位:
Adoptive Immunotherapy against Posttransplant Lymphoprolifrative Disorders
-
批准号:10557032
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$7.42万
-
财政年份:1998
-
负责人:TAKADA Kenzo
-
依托单位:
Studies on Epstein-Barr virus vector for human gene therapy
-
批准号:09044246
-
项目类别:Grant-in-Aid for international Scientific Research
-
资助金额:$3.97万
-
财政年份:1997
-
负责人:TAKADA Kenzo
-
依托单位:
Research on factors regulating the activation of latently infection Epstein-Barr virus
-
批准号:07457589
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$0.96万
-
财政年份:1995
-
负责人:TAKADA Kenzo
-
依托单位:
Research of EBV virus vector for gene therapy
-
批准号:07557029
-
项目类别:Grant-in-Aid for Scientific Research (A)
-
资助金额:$5.76万
-
财政年份:1995
-
负责人:TAKADA Kenzo
-
依托单位:
Studies on Epstein-Barr virus vector and human gene therapy
-
批准号:07044272
-
项目类别:Grant-in-Aid for international Scientific Research
-
资助金额:$3.78万
-
财政年份:1995
-
负责人:TAKADA Kenzo
-
依托单位:
海外基金